China Genetic Testing Market Share, Price Trends, Growth and Opportunity 2022-2027

According to the latest report by IMARC Group, titled "China Genetic Testing Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the China genetic testing market size reached US$ 3.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 8.0 Billion by 2027, exhibiting a growth rate (CAGR) of 17% during 2022-2027. 

Genetic tests identify the changes occurring in the genes, proteins or chromosomes of an individual. They help in determining the chances of a person passing on a genetic disorder to the next generation as well as their vulnerability to a suspected genetic disease. The genetic testing market in China has witnessed rapid development since the establishment of the first genomics company in 1999. The demand for genetic testing services in the country is being driven by factors like aging population, expanding middle class and investments in the healthcare sector. The industry has also attracted international investors owing to rising demand for noninvasive prenatal testing and growing research in the fields of reproductive and oncology health.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request for a PDF sample of this report: https://www.imarcgroup.com/china-genetic-testing-market/requestsample

China Genetic Testing Market Trends:

In an effort to expand its domestic biotechnology sector, the Chinese Government has taken steps in the favor of genetic science development. It identified genomics as a strategic field for the country's social and economic development in its 14th Five-Year Plan. The Government also plans to document the genetic makeup of people from nine different minority groups, in an attempt to decode hereditary information within their genes. Apart from this, the market for direct-to-consumer DNA testing has also experienced massive growth driven by rising priority of personal health and wellness among consumers. This trend has further been supported by technological advancements which have reduced the cost of DNA sequencing services. However, there is a lack of specifically-designed educational programs for training medical genetic professionals in China. 

China Genetic Testing 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

BGI
Berry Genomics Co. ltd.
Daan Gene Co. Ltd
WuXi NextCODE
Annoroad Gene Technology Co. Ltd.
WuXi PharmaTech

Key Market Segmentation:

Breakup by Test Type:

Prenatal Testing
Carrier Testing
New Born Testing
Predictive/Presymptomatic Testing
Diagnostic Testing
Others

Breakup by Disease:

Cancer
Down Syndrome
Thalassemia
Others

Breakup by Technology:

Biochemical
Molecular
Cytogenetic

Breakup by Service Provider:

Hospital Based Laboratories
Independent Laboratories
Specialty Clinics

Breakup by Testing Sample:

Blood
Saliva
Hair
Others

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/china-genetic-testing-market

Key highlights of the report:

Market Performance (2016-2021)
Market Outlook (2022- 2027)
Porter's Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800

About Us:                                                                     

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.